{
  "id": 9490729,
  "title": "Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade",
  "url": "https://urgent.news/2026/09/24/prediction-heres-what-10-000-invested-in-abbvie-stock-with-dividends",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-24T04:30:00.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/09/24/prediction-heres-what-10000-invested-in-abbvie-sto/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "A decade ago, an investment of $10,000 in AbbVie (NYSE: ABBV) stock, with dividends reinvested, would now be worth $61,425.56, reflecting an impressive average annual return of 19.91%. This performance is particularly noteworthy considering the company's exposure to the patent cliff that once threatened its leading drug, Humira. Despite this challenge, AbbVie's stock has risen significantly, currently boasting a high price-to-earnings ratio of 75 and a relatively low dividend yield of 2.6%. Given these factors, it's unlikely that similar returns would be achieved by investing in AbbVie stock today.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade",
        "url": "https://urgent.news/2026/09/24/prediction-heres-what-10-000-invested-in-abbvie-stock-with-dividends-9491803",
        "published": "2026-09-24T04:50:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}